Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Clexane (enoxaparin sodium) - Professional letter HCP

Direct Healthcare Professional Communication, Clexane (enoxaparin sodium): Updates to strength expression, dose regimens in DVT/PE, use in patients with severe renal impairment For hard copies please contact our medical information department at 0845 372 7101 or email [email protected] .

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.